Stem Cell Eye Treatments
Blind patients suffering from a type of eye disease that strikes in childhood will become the second group of people in the world to receive stem cells left over from fertility treatment.
The US Food and Drug Administration (FDA) has given the go-ahead for the controversial transplant of embryonic stem cells into the eyes of patients with Stargardt's macular degeneration, where the light-sensitive retina cells at the back of eye are destroyed. The announcement follows the first injection of embryonic stem cells into a patient in the US who is partially paralysed as a result of a spinal cord injury. Last October, a US biotechnology company, Geron, announced the start of the first clinical trial of embryonic stem cells with the hope of repairing damaged nerves.
International poker champion Liv Boeree teaches decision-making for Big Think Edge.
- Kelly McGonigal teaches "Reset your mindset to reduce stress" for Big Think Edge.
Tracking project establishes northern Argentina is wintering ground of Swainson's hawks
- After one year, only one is still alive.
These quick bursts of inspiration will brighten your day in 10 minutes or less.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.